Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Patent Litigation

full services list
Patent Litigation Image

Litigation

Post-Grant

Prosecution & Counseling

Fish Patent Litigation
High Profile, High Stakes Cases

The world’s leading companies have one thing in common: innovative products and services. That’s why they turn to Fish — the global leader in intellectual property litigation. With 12 offices across the US and in Munich, Germany, Fish protects clients’ most valuable IP business assets around the globe. We’ve earned our elite position by consistently winning the most important, technically sophisticated, bet-the-company patent cases for such clients as Microsoft, 3M, Bose, Samsung, LG, Allergan, and Smith & Nephew.

But one of our greatest strengths is providing long-term plans and solutions for clients, not just litigation advice. Making strategic decisions up front saves clients’ money and helps ensure a successful outcome.

Winning track record at all levels of the judicial system
Our record speaks for itself. Fish handled a total of 321 patent cases in 2015 – over triple as many cases as its nearest competitor but with the same number of people. Most important, we win the largest cases, worth billions of dollars and with whole businesses often on the line. That is why more Fortune 100 companies in the world trust Fish—over any other firm—to handle their mission-critical IP litigation.

For the past thirteen years, Corporate Counsel has named us the #1 patent litigation firm. U.S. News – Best Lawyers ®  recently named  Fish as the Patent Litigation “Law Firm of the Year”, and BTI Consulting has recognized us as an “IP Litigation Powerhouse”, to name a few honors that set us apart from the rest.

We can handle everything and are, quite simply, the absolute best at what we do.

Deep Knowledge, Seasoned Trial Lawyers, Big Wins
Fish has more than 400 attorneys and technology specialists practicing IP strategy and counseling, IP litigation, and commercial litigation. More than 300 attorneys have degrees in science or technology. Add to that the 80 PhDs on our staff, and you get a law firm with unmatched expertise in virtually every technology area. Our deep bench includes more than 70 former law clerks and over 25 former Federal Circuit clerks with in-depth knowledge of these courts, giving us an insider’s edge.

Our litigation teams include top-notch patent prosecutors who have a deep understanding of clients’ technologies, potential prior art, patent laws and rules, and the fine distinctions between claims. Together, we develop creative and winning litigation strategies that other firms would never think of.

In recent years, we have tried more than 20 percent of all the patent cases that were tried to verdict in the United States. Unlike some firms that build a practice around a single rock-star trial lawyer who tries every patent case, our attorneys have expertise in the most complex patent cases at every stage of the litigation: from Markman hearings and motions for summary judgment to trial and appeal.

There is no other firm that can match the quality, breadth, depth, and dominance of our IP litigation practice. This is why Fish wins so many significant cases day in and day out, and is often at the forefront of developing new case law.


View the Fish Litigation Blog
Back to Litigation

Patent Litigation Services




Featured Experience

Highlights

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Patent Litigation

Patent Litigation Team

What's Trending in Patent Litigation

Filter by
Fish Litigation Blog
December 7, 2016
Survey of the Safe Harbor in the United States and Europe
Survey of the Safe Harbor in the United States and Europe
Authors: Brian D. Coggio, Ron Vogel
IP Litigation
Life Sciences
Fish Litigation Blog
December 7, 2016
Federal Circuit Opinion Asetek Danmark a/s v. CMI USA Inc. Cites Patent Damages Treatise
Federal Circuit Opinion <em>Asetek Danmark a/s v. CMI USA Inc.</em> Cites Patent Damages Treatise
Author: Christopher Marchese
IP Litigation
Federal Circuit
News
December 5, 2016
Fish & Richardson Principal John Dragseth Named “Litigation Trailblazer” by The National Law Journal
Press Releases
Press Release
News
December 5, 2016
Juanita Brooks and Jon Singer profiled in National Law Journal's special report "High Stakes, Significant Victories"
Media Coverage
Event
December 15th, 2016 | 1:00 pm EST
Webinar | Minimizing Willful Infringement Post-Halo
Webinar | Minimizing Willful Infringement Post-<em>Halo</em>
Fish Webinar
Fish Litigation Blog
November 30, 2016
Arbitration Risks: Why Arbitration is Not Necessarily Better, Faster, or Cheaper Than Litigation.
Arbitration Risks:  Why Arbitration is Not Necessarily Better, Faster, or Cheaper Than Litigation.
Authors: Mike Gaddis, Ph.D., Taj Clayton, Steven H. Stodghill
IP Litigation
Commercial Litigation
News
November 30, 2016
Fish's John Pegram quoted in World IP Review article "Greener pastures for US patents"
Media Coverage
Article
News
November 29, 2016
Fish & Richardson Receives Top National IP Rankings in Best Law Firms 2017 Report; Named “Law Firm of the Year” for Patent Litigation
Press Releases
News
November 28, 2016
Law360 Rainmaker Q&A with Indranil Mukerji
Media Coverage
Fish Litigation Blog
November 22, 2016
Alert: Federal Circuit Narrows the Types of Patents That Can Be Challenged in a Covered Business Method Review
Alert: Federal Circuit Narrows the Types of Patents That Can Be Challenged in a Covered Business Method Review
Author: John A. Dragseth
IP Litigation
Federal Circuit
News
November 21, 2016
Fish & Richardson Announces Six Principals Named 2016 “Life Science Stars” by LMG Life Sciences
Press Releases
Event
April 2nd, 2017
Patent Resources Group (PRG): Pharma and Biotech Patents: A Hatch-Waxman and BPCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation
Patent Resources Group (PRG): Pharma and Biotech Patents: A Hatch-Waxman and BPCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation
Speaking Engagement
load more topics